Organization | Scripps

Scripps Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: San Diego CA United States (1924)

Organization Overview

First Clinical Trial

1994

NCT00004762

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Goodman, Evan, M.D. | Ida M. and Cecil H. Green Cancer Center at Scripps Clinic | Scripps | Scripps Advanced Clnical Trials | Scripps Cancer Center | Scripps Clinic | Scripps Clinic and Scripps Translational Science Institute | Scripps Clinic, Nutrition Metabolic Research | Scripps Clinic Sleep Center | Scripps Health | Scripps Health/Scripps Clinic | Scripps Mercy | Scripps Research Institute | Scripps Translational Science Institute | Scripps Whittier Diabetes Institute | The Scripps Research Institute | The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research | The Scripps Research Institute- Pearson Center for Alcoholism and Addiction Research | Xiaohua Wu MD

Active Ingredients

Drugs in Phase 4 Trials (17)

acetylsalicylic acid (aspirin) (2 trials)

atorvastatin (lipitor) (1 trial)

bupivacaine (Exparel) (1 trial)

dapagliflozin (farxiga) (1 trial)

diclofenac (voltaren) (1 trial)

enoxaparin (lovenox) (2 trials)

heparin (liquaemin) (2 trials)

hepatitis b vaccine (recombinant) (Recombivax) (1 trial)

inactivated influenza vaccine (2 trials)

ketorolac (acuvail) (1 trial)

naltrexone (revia) (3 trials)

nicotine (nicorette) (1 trial)

ribavirin (virazole) (1 trial)

simeprevir (olysio) (1 trial)

sofosbuvir (sovaldi) (1 trial)

thienoyridine (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Phase 3 Trials (5)

ixazomib (ninlaro) (1 trial)

lenalidomide (revlimid) (2 trials)

rimonabant (2 trials)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 2 Trials (37)

acamprosate (campral) (1 trial)

amifostine (ethyol) (1 trial)

apremilast (otezla) (1 trial)

aprepitant (Emend) (2 trials)

bavisant (1 trial)

betahistine mesilate (1 trial)

cangrelor (kengreal) (1 trial)

cisplatin (platinol) (1 trial)

cladribine (leustatin) (1 trial)

cort118335 (1 trial)

cyclophosphamide (cytoxan) (2 trials)

dasatinib (sprycel) (1 trial)

duloxetine (Cymbalta) (2 trials)

dupilumab (dupixent) (1 trial)

etoposide (vepesid) (1 trial)

fenofibrate (fenoglide) (1 trial)

gabapentin (neurontin) (3 trials)

gemcitabine (gemzar) (1 trial)

hyaluronidase (human recombinant) (Hylenex) (1 trial)

ifetroban (1 trial)

kremezin (1 trial)

lactulose (cephulac) (1 trial)

lidocaine (xylocaine) (1 trial)

live attenuated influenza virus vaccine (Flumist) (1 trial)

melatonin (3 trials)

Methoxypregnenolone (1 trial)

metolazone (zaroxolyn) (1 trial)

mifepristone (mifeprex) (2 trials)

muc1 dendritic cell vaccine (1 trial)

peanut allergen (Palforzia) (1 trial)

povidone-iodine (betadine) (1 trial)

pregabalin (lyrica) (1 trial)

rituximab (rituxan) (2 trials)

sargramostim (leukine) (1 trial)

suvorexant (belsomra) (1 trial)

vemurafenib (zelboraf) (2 trials)

Drugs in Phase 1 Trials (4)

alteplase (Activase) (1 trial)

colchicine (colbenemid) (1 trial)

doxorubicin (Doxil) (1 trial)

evofosfamide (1 trial)

Drugs in Other Trials (14)

acetaminophen (tylenol) (1 trial)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)

autologous hematopoietic stem cells (1 trial)

clopidogrel (plavix) (1 trial)

fentanyl (Innovar) (2 trials)

Filgrastim (neupogen) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

lactobacillus plantarum (1 trial)

lisinopril (zestril) (1 trial)

morphine (2 trials)

omalizumab (xolair) (1 trial)

orange juice (1 trial)

Pediococcus acidilactici (1 trial)

simvastatin (zocor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Coronary Syndrome (Phase 2)

Adenocarcinoma (Phase 2)

Alcohol Drinking (Phase 2)

Alcoholism (Phase 4)

Asthma, Aspirin-Induced (Phase 2)

Atrial Fibrillation (Phase 4)

Body Weight (Phase 2)

Brain Diseases (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Carcinoma, Ovarian Epithelial (Phase 2)

Cardiovascular Diseases (Phase 3)

Cholangitis (Phase 2)

Cholangitis, Sclerosing (Phase 2)

Cognition Disorders (Phase 2)

Cognitive Dysfunction (Phase 2)

Conjunctivitis (Phase 2)

Conjunctivitis, Inclusion (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Coronary Thrombosis (Phase 4)

Cystitis (Phase 2)

Cystitis, Interstitial (Phase 2)

Delirium (Phase 2)

Disease (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Egg Hypersensitivity (Phase 2)

Embolism (Phase 4)

Food Hypersensitivity (Phase 2)

Headache (Phase 4)

Heart Failure (Phase 4)

Heart Failure, Systolic (Phase 4)

Hepatic Encephalopathy (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis C (Phase 4)

Hot Flashes (Phase 2)

Hypersensitivity (Phase 2)

Hypertriglyceridemia (Phase 1)

Leukemia (Phase 2)

Leukemia, Hairy Cell (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Marijuana Abuse (Phase 2)

Migraine Disorders (Phase 4)

Muscular Diseases (Phase 4)

Myocardial Ischemia (Phase 4)

Ovarian Neoplasms (Phase 2)

Peanut Hypersensitivity (Phase 2)

Pericarditis (Phase 1)

Plasmacytoma (Phase 3)

Pulmonary Embolism (Phase 4)

Respiration Disorders (Phase 2)

Respiratory Tract Diseases (Phase 2)

Stroke (Phase 1)

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Venous Thrombosis (Phase 4)

Vulvodynia (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 67
# of Trial APIs: 77